Reflections from Bernstein Private Wealth Management’s Medical Devices Study Group We spend a lot of time with teams who are building the future of medtech. They are solving real problems, making high-stakes decisions and trying to create momentum with limited time and resources. That work can feel lonely at times. It doesn’t have to be….
FDA timelines are getting longer. That changes how medtech startups should build. For medtech founders, FDA clearance has always mattered. But the latest reporting on device review timelines reinforces something we are feeling across the industry: getting to market is taking longer, even as approvals continue to rise. That matters because regulatory timing is no longer just a compliance issue — it is a business…
Congratulations to LIQID Medical, who was named the winner of the 2026 Avio Medtech MVP Pitch Contest at the Medtech MVP Venture & Partnering Conference in Minneapolis, MN. The company earned the $19,000 non-dilutive cash prize after presenting its novel approach to glaucoma treatment. LIQID Medical is developing novel ocular implants for glaucoma treatment, including…
Minneapolis, MN, May 19, 2026, — Avio Medtech Consulting, in partnership with the Destination Medical Center Fredrikson, F&N Med and Mobius Medical, announces that three finalists have been selected for the 2026 Avio Medtech MVP Pitch Contest. The contest, which will award $19,000 in non-dilutive funding, will take place live at the Medtech MVP Conference in Minneapolis, MN on June…
We recently hosted a webinar with Nirav Sheth, Executive and Team Performance Coach and Founder of Stratosphere, LLC. Here are some takeaways. In medtech, growth rarely fails because of the product alone. More often, it stalls when the leadership model that helped launch the company becomes the very thing holding it back. That’s the hard…
Raising capital in medtech has never been harder—and yet some founders consistently move faster, close better rounds, and stay in control of their company’s story. They are not “better pitchers.” They are better sellers. They treat fundraising like a disciplined sales process, not a one-shot performance. They understand that investors are customers, capital is the…
In medtech, turbulence isn’t an exception — it’s the norm. Market cycles shift, capital tightens, regulatory frameworks evolve, and reimbursement realities change faster than most startups can adapt. Yet amid this uncertainty, one truth holds steady: leadership — at both the executive and board level — defines whether a company navigates the storm or gets…
Navigating the New Regulatory Reality with Avio Medtech When the U.S. FDA becomes the headline instead of the gatekeeper, you know the medtech world is in for a ride .At this year’s MD&M Midwest Conference, the panel “FDA, WTF, Now What?”—moderated by Frank Jaskulke, Vice President of Business Development and Sales at Avio Medtech, and…